Simplex Trading
LPCN icon

Simplex Trading’s Lipocine LPCN Stock Holding History

Simplex Trading’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,471
Closed -$7K – 9518
2023
Q1 		$7K Sell
1,471
-8,711
-86% -$67.3K ﹤0.01% 7826
2022
Q4 		$68K Buy
10,182
+1,835
+22% +$13.4K ﹤0.01% 5511
2022
Q3 		$63K Sell
8,347
-429
-5% -$4.79K ﹤0.01% 6114
2022
Q2 		$119K Sell
8,776
-800
-8% -$12.5K ﹤0.01% 5332
2022
Q1 		$223K Buy
9,576
+3,829
+67% +$80.1K ﹤0.01% 5007
2021
Q4 		$96K Sell
5,747
-8,688
-60% -$161K ﹤0.01% 6313
2021
Q3 		$343K Buy
14,435
+23
+0.2% +$508 ﹤0.01% 4690
2021
Q2 		$343K Buy
14,412
+14,141
+5,218% +$333K ﹤0.01% 4752
2021
Q1 		$695K Buy
271
+214
+375% +$6.18K ﹤0.01% 2888
2020
Q4 		$131K Buy
57
+44
+338% +$1.06K ﹤0.01% 5141
2020
Q3 		$31K Sell
13
-37
-74% -$983 ﹤0.01% 6043
2020
Q2 		$106K Buy
+50
New +$648 ﹤0.01% 4732
2019
Q4 		– Sell
-1
Closed -$4K – 7654
2019
Q3 		$4K Sell
1
-1
-50% -$40 ﹤0.01% 6695
2019
Q2 		$5K Hold
2
– – ﹤0.01% 6460
2019
Q1 		$6K Buy
+2
New +$61 ﹤0.01% 6411
2018
Q1 		– Sell
-10
Closed -$5K – 6535
2017
Q4 		$5K Buy
10
+2
+25% +$124 ﹤0.01% 4514
2017
Q3 		$3K Sell
8
-10
-56% -$723 ﹤0.01% 4803
2017
Q2 		$1K Buy
+18
New +$1.17K ﹤0.01% 5643
2017
Q1 		– Sell
-6
Closed -$5K – 6484
2016
Q4 		$5K Buy
+6
New +$380 ﹤0.01% 4356
2016
Q3 		– Sell
-22
Closed -$1K – 6160
2016
Q2 		$1K Buy
+22
New +$3.41K ﹤0.01% 5330
2016
Q1 		– Sell
-1
Closed -$2K – 5937
2015
Q4 		$2K Buy
+1
New +$210 ﹤0.01% 4521

Other funds holding LPCN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Simplex Trading's LPCN Position: Q4 2020 in Review

Simplex Trading sold out of Lipocine (LPCN) in Q4 2020, closing a stake of 1,561 shares — an estimated $37.6K sold.

Simplex Trading first reported a position in LPCN in Q4 2015 and held it in 15 quarters. The position peaked at $251K in Q2 2017. 33 funds tracked by Wall St. Rank hold LPCN as of Q4 2020.

  • Simplex Trading reported no remaining Lipocine position as of Q4 2020 after selling out during the quarter.
  • Simplex Trading sold 1,561 Lipocine shares in Q4 2020, an estimated $37.6K.
  • Simplex Trading first reported a position in Lipocine in Q4 2015 and held it in 15 quarters.
  • Simplex Trading's Lipocine position peaked at $251K in Q2 2017.
  • 33 funds tracked by Wall St. Rank held Lipocine as of Q4 2020.

Based on Simplex Trading's 13F filing for Q4 2020, filed 2 Feb 2021.